Semaglutide—the diabetes and weight-loss drug known by brand names like Ozempic and Wegovy—is continuing to show its potential to treat...
Wegovy
As recently as the onset of COVID-19 four years ago, you probably didn’t know what a glucagon-like peptide 1 agonist,...
Yet despite the ubiquitousness of injectable drugs indicated for people with obesity—such as Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide)—most...
Weight loss drugs are changing the economic picture from many angles. In addition to reshaping the healthcare, retail, and leisure...
Weight-loss drugs are becoming a popular employee perk, with almost a third of workers saying they’d switch jobs to get...
A consumer tech VC confessed to me over breakfast that he was injecting himself with an experimental peptide protocol. His...
Over 40 million Americans have reported using GLP-1 drugs for weight loss, a behavior reshaping everything from the healthcare industry...
Novo Nordisk CEO Mike Doustdar details the company’s Amazon partnership, benefits of Ozempic beyond weight loss and more on ‘The...